Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy

被引：1
|
作者：
Feron, Olivier [1 ,2 ]
Chang, Chih-Hao [3 ]
Vegran, Frederique [4 ,5 ,6 ,7 ]
机构：
[1] UC Louvain, Inst Rech Experimentale & Clin IREC, Pole Pharmacol & Therapeut, Brussels, Belgium
[2] WEL Res Inst, WELBIO Dept, Wavre, Belgium
[3] Jackson Lab, Bar Harbor, ME USA
[4] Univ Bourgogne Franche Comte, Dijon, France
[5] Nutr & Canc Team CAdIR, CRI UMR Lipides 1231, Dijon, France
[6] Ctr Georges Francois Leclerc, UNICANCER, Dijon, France
[7] LipST Labex, Dijon, France
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词：
glycolysis; immunometabolism; fluorodeoxyglucose; gamma-glutamyl hydrolase; GLUT3; glucose transporter; pancreatic cancer;
D O I：
10.3389/fimmu.2023.1171274
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy
    Jarry, Anne
    Gervois, Nadine
    Bossard, Celine
    Germann, Markus
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [42] Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy
    Nunes, Jacques A.
    Wise-Draper, Trisha M.
    Lambert, Claude
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Editorial: Community series in adenosine pathways in cancer immunity and immunotherapy, volume II
    Fu, Junjiang
    Antonioli, Luca
    Zheng, Xiaoli
    El-Far, Ali H.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [44] Targeting lipid metabolism in regulatory T cells for enhancing cancer immunotherapy
    Yang, Liu
    Wang, Xingyue
    Wang, Shurong
    Shen, Jing
    Li, Yaling
    Wan, Shengli
    Xiao, Zhangang
    Wu, Zhigui
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2025, 1880 (02):
  • [45] Targeting the tumor microenvironment and T cell metabolism for effective cancer immunotherapy
    Hope, Helen Carrasco
    Salmond, Robert J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 (08) : 1147 - 1152
  • [46] Targeting metabolism of breast cancer and its implications in T cell immunotherapy
    Zou, Jialuo
    Mai, Cunjun
    Lin, Zhiqin
    Zhou, Jian
    Lai, Guie
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [47] Overcoming cancer therapeutic resistance by targeting dysregulated glucose metabolism
    Zhao, Yuhua
    Zhou, Ming
    LeDoux, Susan
    Wilson, Glenn
    Yu, Dihua
    Price, Janet
    Fodstad, Oystein
    Tan, Ming
    CANCER RESEARCH, 2012, 72
  • [48] Targeting Glucose Metabolism in HER2+ Breast Cancer
    Telang, Sucheta
    Chang, Simone
    Burlison, Joseph
    FASEB JOURNAL, 2021, 35
  • [49] Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition
    Yan, Liang
    Tu, Bo
    Yao, Jun
    Gong, Jing
    Carugo, Alessandro
    Bristow, Christopher A.
    Wang, Qiuyun
    Zhu, Cihui
    Dai, Bingbing
    Kang, Ya'an
    Han, Leng
    Feng, Ningping
    Jin, Yanqing
    Fleming, Jason
    Heffernan, Timothy P.
    Yao, Wantong
    Ying, Haoqiang
    CANCER RESEARCH, 2021, 81 (15) : 4054 - 4065
  • [50] Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy
    Guo, Xiaomeng
    Bai, Junqiang
    Wang, Xinmiao
    Guo, Shutian
    Shang, Zhengjun
    Shao, Zhe
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 154
12345